Barri, Mark Zian P.

HRN: 22-57-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2023
OXACILLIN 500MG (VIAL)
02/05/2023
02/12/2023
IV
45mg
Q6 Hours
Seborrheic Dermatitis With Bacterial Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: